SlideShare a Scribd company logo
Multi-Media Prevention
Presenters:
• Rosemary Bretthauer-Mueller, Digital Communication and Marketing
Lead, National Center for Injury Prevention and Control, CDC
• LeShaundra Cordier Scott, MPH, CHES, Health Communications Team
Lead, National Center for Injury Prevention and Control, CDC
• Peter DeBenedittis, PhD, President, Media Literacy for Prevention
• Jan Cairnes, BBA, CPP, Director of Prevention Services, Hanley Center
Foundation
Prevention Track
Moderator: Mary Colvin, CPA, MBA, Vice President and Chief Operating
Officer, Kentucky Employers’ Mutual Insurance, and Member, Operation
UNITE Board of Directors
Disclosures
Rosemary Bretthauer-Mueller; Jan Cairnes, BBA,
CPP; Peter DeBenedittis, PhD; LeShaundra
Cordier Scott, MPH, CHES; and Mary Colvin, CPA,
MBA, have disclosed no relevant, real, or
apparent personal or professional financial
relationships with proprietary entities that
produce healthcare goods and services.
Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or devices
with any commercial interest related to the content of
this activity of any amount during the past 12 months.
• The following planners/managers have the following to
disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
Learning Objectives
1. Describe the CDC’s digital Rx drug overdose
prevention campaign.
2. Identify best practices for delivering prevention
messages digitally.
3. Compare and contrast Expectancy Challenge Theory
and risk/protective factors as the basis for adolescent
prevention programs.
4. Explain how some Florida schools are using media
literacy education in single-session prevention
programs based on expectancy challenge theory.
5. Provide accurate and appropriate counsel as part of
the treatment team.
Prevention Track:
Multi-Media Prevention
CDC’s #RxProblem Social Media Campaign
Telling Stories to Influence Influencers
DISCLOSURE
Rosie Bretthauer-Mueller has disclosed no relevant, real or apparent
personal or professional financial relationships with proprietary entities
that produce health care goods and services.
DISCLOSURE
This project was made possible by Michelle Canada, MBA, Erin Connelly,
MPAff, Cassie Sheldon Strawn, MA, and many other talented people who
remain unnamed because I didn’t want to track down their real or
apparent relationships.
LEARNING OBJECTIVES
1. Describe the CDC’s digital Rx drug overdose prevention campaign.
2. Identify best practices for delivering prevention messages digitally.
3. Compare and contrast Expectancy Challenge Theory and risk/protective
factors as the basis for adolescent prevention programs.
4. Explain how some Florida schools are using media literacy education in
single-session prevention programs based on expectancy challenge
theory.
5. Provide accurate and appropriate counsel as part of the treatment team.
LEARNING OBJECTIVES
1. Describe the CDC’s digital Rx drug overdose prevention campaign.
2. Identify best practices for delivering prevention messages digitally.
3. Compare and contrast Expectancy Challenge Theory and risk/protective
factors as the basis for adolescent prevention programs.
4. Explain how some Florida schools are using media literacy education in
single-session prevention programs based on expectancy challenge
theory.
5. Provide accurate and appropriate counsel as part of the treatment team.
My Story
Avery’s Story
Brad’s Story
Kevin’s Story
Danielle & Melanda
James &
Vanessa
Jason
Short Video Stories
Video 1
Marty’s Story
Billy’s Story
Kay’s Story
April’s Story
Dr. Houry’s Story
Rep. Rogers’ and Dr. Frieden’s Story
Rebecca’s Story
onassis217’s Story
Free #RxProblem Materials
Indiana Health Department
Salt Lake County Health Dept.
Hazelden Betty Ford
Barb’s Story
@HHSGov Tweets Story
HHS Secretary Burwell
Sen. Joe Manchin, WV
Sen. Mitch McConnell, KY
Rep. Richard Hudson, NC
Campaign Issue
April 6 – May 15, 2015
Metrics
• Supporting July Vital Signs
Integrating Press and Social Media
• Supporting July Vital Signs
• 10,000 impressions
• 135 engagements (clicks,
retweets, replies)
Integrating Press and Social Media
May 16, 2015 – February 29, 2016
More Metrics
The Story of
Chad’s Hope
Video 2
The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the U.S. Department
of Health and Human Services, or the U.S. Centers for Disease Control and Prevention. Use of trade names and commercial sources is for
identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for
Disease Control and Prevention.
Thank you for listening to ours
#RxProblem
CDC.gov/DrugOverdose @CDCInjury @DebHouryCDC
TELL YOUR STORY
Prescription Drug Overdose:
Digital Communications
Multi-Media Prevention
LeShaundra Cordier, MPH, CHES
Communications Team Lead
Division of Unintentional Injury Prevention
CDC’s Injury Center
Disclosure Statement
LeShaundra Cordier, MPH, CHES, has
disclosed no relevant, real or apparent
personal or professional financial
relationships with proprietary entities that
produce health care goods and services.
Learning Objectives
1. Describe the CDC’s digital Rx drug overdose
prevention campaign.
2. Identify best practices for delivering prevention
messages digitally.
3. Compare and contrast Expectancy Challenge Theory
and risk/protective factors as the basis for adolescent
prevention programs.
4. Explain how some Florida schools are using media
literacy education in single-session prevention
programs based on expectancy challenge theory.
5. Provide accurate and appropriate counsel as part of
the treatment team.
Outline
• The Problem: Prescription Drug Overdose
Epidemic
• Process: Communication Planning & Message
Development
• Solutions: Digital Communications Efforts
• Resources: Tools You Can Use
• More than 40 people die every
day from overdoses involving
prescription opioids
• A four-fold increase in opioid
prescribing created and
continues to fuel the epidemic
• Primary care providers account
for ~50% of opioid pain
medications dispensed
Problem: Prescription Drug Overdose
Process: Communications Planning
• Goals and Objectives
• Increase awareness about opioids and risk
• Address public concerns
• Strategy
• Identify and understand audiences
• Identify communication barriers
• Implementation
• Use appropriate channels and messages
• Engagement (when & how)
Process: Developing messages
• Target Audiences: patients, providers, & states
• Crisis and Risk Communication
• Concise and focused
• Actionable
• Repeated
• Clear (use plain language)
• Caring and sharing messages
Solutions: PDO Digital Communications
• Website
• Data Visualization (graphics and infographics)
• Email platforms (GovDelivery)
• CDC Vital Signs
• Social Media
Solution: Website
• CDC launched a prescription drug overdose
responsive design website
– Site consists of over 30 webpages
– Designed to integrate PDO specific image- and
audience- based messages
– Relaunched as an opioid overdose site Mar 2016
• Goals and objectives:
– Increase information sharing and audience knowledge
– Drive traffic to new data and accurate messages
– Acknowledge action and improve transparency
http://www.cdc.gov/drugoverdose/
Solution: Data Visualization
• Helping audiences
understand data
• Presenting useful
information in pictorial
or graphic form
• Displaying important
patterns, trends,
concepts in an easily
accessible format
Solution: Email Platforms
• Quickly and directly
reach large audiences
with minimal cost
• Disseminate content
regularly or as needed
• Target PDO subscribers
and key partners
– 53,220 GovDelivery users
– 61+ Organizations
– 36 States
Solution: CDC Vital Signs
• Monthly report
• MMWR Early Release
• Graphic fact sheet and media release
• PDO Related Vital Signs
– Today’s Heroin Epidemic
– Opioid Painkiller Prescribing - Where You Live Makes a
Difference
– Prescription Painkiller Overdoses - A Growing Epidemic,
Especially Among Women
– Use and Abuse of Methadone as a Painkiller
– Prescription Painkiller Overdoses in the US
Resources: Tools You Can Use
PDO Communications Tools
(link to resource page)
• Media materials
– Press release
– Digital ads & graphics
• Provider & patient materials
– Checklist for providers
– Fact sheets & posters
– Web banners & badges
– Social media posts
– Publications
Additional Tools
• CDC Clear Communication Index http://www.cdc.gov/ccindex/index.html
• Social Media at CDC http://www.cdc.gov/SocialMedia/index.html
Single Session, Evidence Based
Alcohol Prevention
Jan Cairnes. Certified Prevention Professional
Vice President of Prevention Services
Hanley Center Foundation
Peter DeBenedittis, Ph.D.
Media Literacy for Prevention
Alcohol Expectancies:
your “beliefs” about the
effects of drinking alcohol
You can determine your alcohol expectancies
by answering the question:
How do you think a person feels
after a few drinks?
Physical vs. Mental Effects
• Physical effects are direct pharmacological or
biological effects of a drug.
• Mental effects are effects people associate
with a drug, whether or not they’re really
caused by the drug.
• Mental effects “really” happen, but they’re
not caused by the drug. They’re placebo
effects.
Memory Map of Alcohol Effects
Arousal/Sedation Dimension
Positive/
Negative
Dimension
Hyper
Forgetful
Loud
Stupid
Crazy
Dizzy
Sick
Sleepy
Slow
Scared
Cool
Talkative
Active
Carefree
Funny
Friendly
Less Nervous
Outgoing
Fun
Happy
Sad
Relaxed
Smart
Quiet
Sexy
Neurons that Fire Together, Wire Together
When two things happen at the same time,
your brain makes one thing out of it
The Active Part Wins
Whatever part of your brain you’re
using determines your behavior
Brain Science Rules
To help your read the Alcohol Memory Map
Memory Map of Alcohol Effects
Arousal/Sedation Dimension
Positive/
Negative
Dimension
Hyper
Forgetful
Loud
Stupid
Crazy
Dizzy
Sick
Sleepy
Slow
Scared
Cool
Talkative
Active
Carefree
Funny
Friendly
Less Nervous
Outgoing
Fun
Happy
Sad
Relaxed
Smart
Quiet
Sexy
Barriers to School-Based Prevention
Peter DeBenedittis, Ph.D.
Media Literacy for Prevention
pdebenedittis@medialiteracy.net
Jan Cairnes, CPP
Vice President of Prevention Services
Hanley Center Foundation
jan@hanleycenterfoundation.org
561-841-1122
Multi-Media Prevention
Presenters:
• Rosemary Bretthauer-Mueller, Digital Communication and Marketing
Lead, National Center for Injury Prevention and Control, CDC
• LeShaundra Cordier Scott, MPH, CHES, Health Communications Team
Lead, National Center for Injury Prevention and Control, CDC
• Peter DeBenedittis, PhD, President, Media Literacy for Prevention
• Jan Cairnes, BBA, CPP, Director of Prevention Services, Hanley Center
Foundation
Prevention Track
Moderator: Mary Colvin, CPA, MBA, Vice President and Chief Operating
Officer, Kentucky Employers’ Mutual Insurance, and Member, Operation
UNITE Board of Directors

More Related Content

What's hot

Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_ppt
OPUNITE
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
OPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
OPUNITE
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
OPUNITE
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
OPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
OPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
OPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
OPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
OPUNITE
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
OPUNITE
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
OPUNITE
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
OPUNITE
 

What's hot (20)

Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_ppt
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriendRx16 tpp tues_330_1_gavin_2saddy_3gastfriend
Rx16 tpp tues_330_1_gavin_2saddy_3gastfriend
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armaganRx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
Rx16 pdmp tues_200_1_o_neill_2carter_3small_armagan
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 

Viewers also liked

Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Rx16 tpp wed_111_panel_paduda_pew
Rx16 tpp wed_111_panel_paduda_pewRx16 tpp wed_111_panel_paduda_pew
Rx16 tpp wed_111_panel_paduda_pew
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
OPUNITE
 
Web only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2badaWeb only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2bada
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
OPUNITE
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
OPUNITE
 

Viewers also liked (18)

Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Rx16 tpp wed_111_panel_paduda_pew
Rx16 tpp wed_111_panel_paduda_pewRx16 tpp wed_111_panel_paduda_pew
Rx16 tpp wed_111_panel_paduda_pew
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Web only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2badaWeb only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2bada
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 

Similar to Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy

Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...
Mohammad Shahnewaz
 
Role of digital: social media in consumerism
Role of digital: social media in consumerismRole of digital: social media in consumerism
Role of digital: social media in consumerism
Cepal & Co.
 
Master chef in healthcare- integrating social media - @DrNic1
Master chef in healthcare- integrating social media - @DrNic1Master chef in healthcare- integrating social media - @DrNic1
Master chef in healthcare- integrating social media - @DrNic1
Nick van Terheyden
 
Recap - Patient Engagement: The Future of Healthcare Communications Summit
Recap - Patient Engagement: The Future of Healthcare Communications SummitRecap - Patient Engagement: The Future of Healthcare Communications Summit
Recap - Patient Engagement: The Future of Healthcare Communications Summit
prnewswire
 
Social Media Possibilities for Public Health
Social Media Possibilities for Public HealthSocial Media Possibilities for Public Health
Social Media Possibilities for Public HealthMaureen Donnellan
 
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn PartnersmHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
Levi Shapiro
 
VAFP Social Media Presentation
VAFP Social Media PresentationVAFP Social Media Presentation
VAFP Social Media Presentation
Mark Ryan
 
Social Media & Healthcare - Opportunities & Obstacles
Social Media & Healthcare - Opportunities & ObstaclesSocial Media & Healthcare - Opportunities & Obstacles
Social Media & Healthcare - Opportunities & Obstacles
Performics.Convonix
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
A.R.J. (Rob) Halkes
 
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
Mad*Pow
 
Stfm pci 2011
Stfm pci 2011Stfm pci 2011
Stfm pci 2011
Mark Ryan
 
Perficient Perspectives: The Evolution of Social Media in Healthcare
Perficient Perspectives: The Evolution of Social Media in HealthcarePerficient Perspectives: The Evolution of Social Media in Healthcare
Perficient Perspectives: The Evolution of Social Media in Healthcare
Perficient, Inc.
 
Content Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare OrganizationsContent Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare Organizations
AIS Media, Inc.
 
Social Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For SlideshareSocial Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For Slideshare
Mike Newton-Ward
 
Social Media Strategy for Behavioral Healthcare
Social Media Strategy for Behavioral HealthcareSocial Media Strategy for Behavioral Healthcare
Social Media Strategy for Behavioral HealthcareAmy Marshall
 
Social Media for Diabetes: Step Up to the Genius Bar
Social Media for Diabetes: Step Up to the Genius BarSocial Media for Diabetes: Step Up to the Genius Bar
Social Media for Diabetes: Step Up to the Genius Bar
Diabetes Hands Foundation
 
NCCMT Spotlight Webinar: Clear Communication Index
NCCMT Spotlight Webinar: Clear Communication Index NCCMT Spotlight Webinar: Clear Communication Index
NCCMT Spotlight Webinar: Clear Communication Index
The National Collaborating Centre for Methods and Tools
 
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
Mad*Pow
 

Similar to Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy (20)

Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...Social Media and Health Care – How Does the Industry Navigate the New Communi...
Social Media and Health Care – How Does the Industry Navigate the New Communi...
 
Role of digital: social media in consumerism
Role of digital: social media in consumerismRole of digital: social media in consumerism
Role of digital: social media in consumerism
 
Master chef in healthcare- integrating social media - @DrNic1
Master chef in healthcare- integrating social media - @DrNic1Master chef in healthcare- integrating social media - @DrNic1
Master chef in healthcare- integrating social media - @DrNic1
 
Recap - Patient Engagement: The Future of Healthcare Communications Summit
Recap - Patient Engagement: The Future of Healthcare Communications SummitRecap - Patient Engagement: The Future of Healthcare Communications Summit
Recap - Patient Engagement: The Future of Healthcare Communications Summit
 
Social Media Possibilities for Public Health
Social Media Possibilities for Public HealthSocial Media Possibilities for Public Health
Social Media Possibilities for Public Health
 
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn PartnersmHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
mHealth israel_B2B2C Bootcamp 2016_Gil Bashe_Finn Partners
 
VAFP Social Media Presentation
VAFP Social Media PresentationVAFP Social Media Presentation
VAFP Social Media Presentation
 
Social Media & Healthcare - Opportunities & Obstacles
Social Media & Healthcare - Opportunities & ObstaclesSocial Media & Healthcare - Opportunities & Obstacles
Social Media & Healthcare - Opportunities & Obstacles
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
 
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
Social Media and Patient Centric Design, Facilitating Provider-Patient Relati...
 
Stfm pci 2011
Stfm pci 2011Stfm pci 2011
Stfm pci 2011
 
Phil Baumann
Phil BaumannPhil Baumann
Phil Baumann
 
Perficient Perspectives: The Evolution of Social Media in Healthcare
Perficient Perspectives: The Evolution of Social Media in HealthcarePerficient Perspectives: The Evolution of Social Media in Healthcare
Perficient Perspectives: The Evolution of Social Media in Healthcare
 
Content Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare OrganizationsContent Marketing Rules for Healthcare Organizations
Content Marketing Rules for Healthcare Organizations
 
Social Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For SlideshareSocial Media Vs. Social Marketing For Slideshare
Social Media Vs. Social Marketing For Slideshare
 
Can Social Media Save Lives?
Can Social Media Save Lives?Can Social Media Save Lives?
Can Social Media Save Lives?
 
Social Media Strategy for Behavioral Healthcare
Social Media Strategy for Behavioral HealthcareSocial Media Strategy for Behavioral Healthcare
Social Media Strategy for Behavioral Healthcare
 
Social Media for Diabetes: Step Up to the Genius Bar
Social Media for Diabetes: Step Up to the Genius BarSocial Media for Diabetes: Step Up to the Genius Bar
Social Media for Diabetes: Step Up to the Genius Bar
 
NCCMT Spotlight Webinar: Clear Communication Index
NCCMT Spotlight Webinar: Clear Communication Index NCCMT Spotlight Webinar: Clear Communication Index
NCCMT Spotlight Webinar: Clear Communication Index
 
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
Communities of Care, Strategic Social Interaction Design for Healthcare - ide...
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy

  • 1. Multi-Media Prevention Presenters: • Rosemary Bretthauer-Mueller, Digital Communication and Marketing Lead, National Center for Injury Prevention and Control, CDC • LeShaundra Cordier Scott, MPH, CHES, Health Communications Team Lead, National Center for Injury Prevention and Control, CDC • Peter DeBenedittis, PhD, President, Media Literacy for Prevention • Jan Cairnes, BBA, CPP, Director of Prevention Services, Hanley Center Foundation Prevention Track Moderator: Mary Colvin, CPA, MBA, Vice President and Chief Operating Officer, Kentucky Employers’ Mutual Insurance, and Member, Operation UNITE Board of Directors
  • 2. Disclosures Rosemary Bretthauer-Mueller; Jan Cairnes, BBA, CPP; Peter DeBenedittis, PhD; LeShaundra Cordier Scott, MPH, CHES; and Mary Colvin, CPA, MBA, have disclosed no relevant, real, or apparent personal or professional financial relationships with proprietary entities that produce healthcare goods and services.
  • 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  • 4. Learning Objectives 1. Describe the CDC’s digital Rx drug overdose prevention campaign. 2. Identify best practices for delivering prevention messages digitally. 3. Compare and contrast Expectancy Challenge Theory and risk/protective factors as the basis for adolescent prevention programs. 4. Explain how some Florida schools are using media literacy education in single-session prevention programs based on expectancy challenge theory. 5. Provide accurate and appropriate counsel as part of the treatment team.
  • 5. Prevention Track: Multi-Media Prevention CDC’s #RxProblem Social Media Campaign Telling Stories to Influence Influencers
  • 6. DISCLOSURE Rosie Bretthauer-Mueller has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services.
  • 7. DISCLOSURE This project was made possible by Michelle Canada, MBA, Erin Connelly, MPAff, Cassie Sheldon Strawn, MA, and many other talented people who remain unnamed because I didn’t want to track down their real or apparent relationships.
  • 8. LEARNING OBJECTIVES 1. Describe the CDC’s digital Rx drug overdose prevention campaign. 2. Identify best practices for delivering prevention messages digitally. 3. Compare and contrast Expectancy Challenge Theory and risk/protective factors as the basis for adolescent prevention programs. 4. Explain how some Florida schools are using media literacy education in single-session prevention programs based on expectancy challenge theory. 5. Provide accurate and appropriate counsel as part of the treatment team.
  • 9. LEARNING OBJECTIVES 1. Describe the CDC’s digital Rx drug overdose prevention campaign. 2. Identify best practices for delivering prevention messages digitally. 3. Compare and contrast Expectancy Challenge Theory and risk/protective factors as the basis for adolescent prevention programs. 4. Explain how some Florida schools are using media literacy education in single-session prevention programs based on expectancy challenge theory. 5. Provide accurate and appropriate counsel as part of the treatment team.
  • 11.
  • 12.
  • 13.
  • 17. Danielle & Melanda James & Vanessa Jason Short Video Stories Video 1
  • 23. Rep. Rogers’ and Dr. Frieden’s Story
  • 28. Salt Lake County Health Dept.
  • 37. April 6 – May 15, 2015 Metrics
  • 38. • Supporting July Vital Signs Integrating Press and Social Media
  • 39. • Supporting July Vital Signs • 10,000 impressions • 135 engagements (clicks, retweets, replies) Integrating Press and Social Media
  • 40. May 16, 2015 – February 29, 2016 More Metrics
  • 41. The Story of Chad’s Hope Video 2
  • 42. The findings and conclusions in this presentation are those of the authors and do not necessarily represent the views of the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention. Use of trade names and commercial sources is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services, or the U.S. Centers for Disease Control and Prevention. Thank you for listening to ours #RxProblem CDC.gov/DrugOverdose @CDCInjury @DebHouryCDC TELL YOUR STORY
  • 43. Prescription Drug Overdose: Digital Communications Multi-Media Prevention LeShaundra Cordier, MPH, CHES Communications Team Lead Division of Unintentional Injury Prevention CDC’s Injury Center
  • 44. Disclosure Statement LeShaundra Cordier, MPH, CHES, has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services.
  • 45. Learning Objectives 1. Describe the CDC’s digital Rx drug overdose prevention campaign. 2. Identify best practices for delivering prevention messages digitally. 3. Compare and contrast Expectancy Challenge Theory and risk/protective factors as the basis for adolescent prevention programs. 4. Explain how some Florida schools are using media literacy education in single-session prevention programs based on expectancy challenge theory. 5. Provide accurate and appropriate counsel as part of the treatment team.
  • 46. Outline • The Problem: Prescription Drug Overdose Epidemic • Process: Communication Planning & Message Development • Solutions: Digital Communications Efforts • Resources: Tools You Can Use
  • 47. • More than 40 people die every day from overdoses involving prescription opioids • A four-fold increase in opioid prescribing created and continues to fuel the epidemic • Primary care providers account for ~50% of opioid pain medications dispensed Problem: Prescription Drug Overdose
  • 48. Process: Communications Planning • Goals and Objectives • Increase awareness about opioids and risk • Address public concerns • Strategy • Identify and understand audiences • Identify communication barriers • Implementation • Use appropriate channels and messages • Engagement (when & how)
  • 49. Process: Developing messages • Target Audiences: patients, providers, & states • Crisis and Risk Communication • Concise and focused • Actionable • Repeated • Clear (use plain language) • Caring and sharing messages
  • 50.
  • 51. Solutions: PDO Digital Communications • Website • Data Visualization (graphics and infographics) • Email platforms (GovDelivery) • CDC Vital Signs • Social Media
  • 52. Solution: Website • CDC launched a prescription drug overdose responsive design website – Site consists of over 30 webpages – Designed to integrate PDO specific image- and audience- based messages – Relaunched as an opioid overdose site Mar 2016 • Goals and objectives: – Increase information sharing and audience knowledge – Drive traffic to new data and accurate messages – Acknowledge action and improve transparency
  • 54. Solution: Data Visualization • Helping audiences understand data • Presenting useful information in pictorial or graphic form • Displaying important patterns, trends, concepts in an easily accessible format
  • 55. Solution: Email Platforms • Quickly and directly reach large audiences with minimal cost • Disseminate content regularly or as needed • Target PDO subscribers and key partners – 53,220 GovDelivery users – 61+ Organizations – 36 States
  • 56. Solution: CDC Vital Signs • Monthly report • MMWR Early Release • Graphic fact sheet and media release • PDO Related Vital Signs – Today’s Heroin Epidemic – Opioid Painkiller Prescribing - Where You Live Makes a Difference – Prescription Painkiller Overdoses - A Growing Epidemic, Especially Among Women – Use and Abuse of Methadone as a Painkiller – Prescription Painkiller Overdoses in the US
  • 57. Resources: Tools You Can Use PDO Communications Tools (link to resource page) • Media materials – Press release – Digital ads & graphics • Provider & patient materials – Checklist for providers – Fact sheets & posters – Web banners & badges – Social media posts – Publications Additional Tools • CDC Clear Communication Index http://www.cdc.gov/ccindex/index.html • Social Media at CDC http://www.cdc.gov/SocialMedia/index.html
  • 58. Single Session, Evidence Based Alcohol Prevention Jan Cairnes. Certified Prevention Professional Vice President of Prevention Services Hanley Center Foundation Peter DeBenedittis, Ph.D. Media Literacy for Prevention
  • 59. Alcohol Expectancies: your “beliefs” about the effects of drinking alcohol You can determine your alcohol expectancies by answering the question: How do you think a person feels after a few drinks?
  • 60. Physical vs. Mental Effects • Physical effects are direct pharmacological or biological effects of a drug. • Mental effects are effects people associate with a drug, whether or not they’re really caused by the drug. • Mental effects “really” happen, but they’re not caused by the drug. They’re placebo effects.
  • 61. Memory Map of Alcohol Effects Arousal/Sedation Dimension Positive/ Negative Dimension Hyper Forgetful Loud Stupid Crazy Dizzy Sick Sleepy Slow Scared Cool Talkative Active Carefree Funny Friendly Less Nervous Outgoing Fun Happy Sad Relaxed Smart Quiet Sexy Neurons that Fire Together, Wire Together When two things happen at the same time, your brain makes one thing out of it The Active Part Wins Whatever part of your brain you’re using determines your behavior Brain Science Rules To help your read the Alcohol Memory Map
  • 62. Memory Map of Alcohol Effects Arousal/Sedation Dimension Positive/ Negative Dimension Hyper Forgetful Loud Stupid Crazy Dizzy Sick Sleepy Slow Scared Cool Talkative Active Carefree Funny Friendly Less Nervous Outgoing Fun Happy Sad Relaxed Smart Quiet Sexy
  • 63.
  • 65. Peter DeBenedittis, Ph.D. Media Literacy for Prevention pdebenedittis@medialiteracy.net Jan Cairnes, CPP Vice President of Prevention Services Hanley Center Foundation jan@hanleycenterfoundation.org 561-841-1122
  • 66. Multi-Media Prevention Presenters: • Rosemary Bretthauer-Mueller, Digital Communication and Marketing Lead, National Center for Injury Prevention and Control, CDC • LeShaundra Cordier Scott, MPH, CHES, Health Communications Team Lead, National Center for Injury Prevention and Control, CDC • Peter DeBenedittis, PhD, President, Media Literacy for Prevention • Jan Cairnes, BBA, CPP, Director of Prevention Services, Hanley Center Foundation Prevention Track Moderator: Mary Colvin, CPA, MBA, Vice President and Chief Operating Officer, Kentucky Employers’ Mutual Insurance, and Member, Operation UNITE Board of Directors